The Latest

Roseville, Calif.-based Adventist Health said it is seeing measurable gains from bringing revenue cycle operations in-house, according to its March 19 financial report. The 27-hospital system said insourcing revenue cycle operations resulted in days in accounts receivable of 56 days…

Across many health systems, anesthesia is still approached primarily as a staffing problem. It is not. It is an enterprise operating model problem. When anesthesia is treated as a narrow labor issue rather than a strategic platform, the consequences extend…

Indiana (Noblesville) Orthopedic Institute is expanding by opening a new clinic, adding a physician and growing its service lines.  The organization is opening an outpatient clinic in Greenwood, Ind., on March 30, according to a March 24 news release from…

Valdosta, Ga.-based SGMC Health launched a platform that allows patients to order and track their hospital meals digitally. The platform, MyDining, enables patients to order meals using in-room tablets, personal devices or assistance from a patient dining associate or call…

Amid persistent shortages in nursing and other clinical specialties, health system human resources leaders are becoming more strategic about where compensation dollars are allocated. Ongoing budget constraints and uneven labor market conditions require a more targeted approach to compensation rather…

New Haven, Conn.-based Yale researchers are studying whether GLP-1 drugs may extend beyond diabetes and obesity treatment to address addiction, NBC Connecticut reported March 27.  Rajita Sinha, PhD, director of the Yale Interdisciplinary Stress Center, studied semaglutide in people with obesity and…

The FDA has approved Novo Nordisk’s Awiqli (insulin icodec-abae), making it the first once-weekly basal insulin available in the U.S. for adults with Type 2 diabetes. Awiqli is indicated as an adjunct to diet and exercise and is intended to…

The FDA has granted accelerated approval to Kresladi (marnetegragene autotemcel), the first gene therapy for severe leukocyte adhesion deficiency Type 1, a rare pediatric immune disorder. Kresladi is indicated for pediatric patients with the condition caused by biallelic ITGB2 variants…

GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound are FDA-approved for diabetes and weight loss, but growing evidence suggests their effects may extend beyond blood sugar and body fat, according to a March 27 analysis by The Washington Post. Researchers…